Table 2 Univariate and multivariate analyses of predictive factors for overall survival

Age

0.63

0.84 (0.43–1.7)

0.41

0.7 (0.3–1.6)

BMI

0.33

1.4 (0.7–2.8)

0.03

2.9 (1.1–7.8)

Urine cytology

0.41

1.3 (0.68–2.6)

0.26

1.5 (0.72–3.3)

Diabetes history

0.58

0.76 (0.29–2)

eGFR

0.6

0.83 (0.4–1.7)

0.25

0.62 (0.28–1.4)

Gender

0.035

2.1 (1.1–4.1)

0.013

2.8 (1.2–6.4)

Tumor grade

0.66

0.72 (0.17–3)

0.22

2.7 (0.55–13)

Hypertension history

0.54

0.81 (0.41–1.6)

0.14

0.54 (0.23–1.2)

ALT/AST

0.77

1.1 (0.51–2.5)

Hydronephrosis

0.2

1.6 (0.78–3.2)

0.1

2.3 (0.84–6)

Renal pelvic carcinoma

0.073

0.5 (0.23–1.1)

0.1

0.44 (0.16–1.2)

Ureteral carcinoma

0.33

1.4 (0.71–2.7)

Tumor in both

0.32

1.4 (0.7–3)

0.068

2.5 (0.93–6.9)

Tumor side

0.62

0.84 (0.43–1.6)

0.74

0.87 (0.4–1.9)

SII

0.08

0.54 (0.27–1.1)

0.0075

0.32 (0.14–0.74)

Tumor size

0.55

0.81 (0.4–1.6)

0.21

0.61 (0.28–1.3)

Tumor stage

0.07

1.9 (0.95–3.8)

0.004

3.4 (1.5–7.8)

Ureteroscopy

0.53

1.2 (0.62–2.5)